Generalizability of FIGARO-DKD and FIDELIO-DKD Trial Criteria to the US Population Eligible for Finerenone

J Am Heart Assoc. 2022 Apr 5;11(7):e025079. doi: 10.1161/JAHA.121.025079. Epub 2022 Mar 21.

Authors

Nicholas Chiu¹, Rahul Aggarwal¹, George L Bakris², Bertram Pitt³, Deepak L Bhatt⁴

Affiliations

¹ Department of Medicine Beth Israel Deaconess Medical CenterHarvard Medical School Boston MA.
² University of Chicago IL.
³ University of Michigan Ann Arbor MI.
⁴ Brigham and Women's Hospital Heart and Vascular Center Harvard Medical School Boston MA.

No abstract available

Keywords: CKD; albuminuria; diabetes; finerenone; generalizability.

Publication types

Letter

MeSH terms

Albuminuria
Diabetes Mellitus, Type 2*
Diabetic Nephropathies*
Humans
Naphthyridines

Substances

Naphthyridines
finerenone